US Post-Market Study of the Surfacer System for Central Venous Access
This study is looking at the Surfacer® Inside-Out® Access Catheter System. This device helps doctors get central venous access (a way to put a catheter, or thin tube, into a large vein) in people who have blockages in their upper body veins or other issues that make it hard to get access in the usual way. The study wants to see how well the device works to get central venous access and if there are any problems within 24 hours. You might be able to join if you are 18 or older, need central venous access, and have conditions that prevent conventional access. The study is currently unclear on its recruitment status and plans to enroll at least 30 participants.
- Study design
- This is an observational study, meaning researchers will watch how the Surfacer System is used in real-world settings. It will enroll at least 30 participants across multiple sites.
- What's involved
- You would be treated with the Surfacer System according to its approved use. Your data would be collected, and you would sign an informed consent form.
- Compensation
- Not stated in the trial record.
- Follow-up
- Researchers will check for operational success and adverse events within 24 hours after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
US Post-Market Surveillance Study of the Surfacer System
At a glance
Conditions
Where it's being run
9 sites across 7 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Central Venous Access operational24 hours
safe insertion of the device to facilitate central venous access
- Incidence of adverse events through 24 hours24 hours
no procedural adverse events or peri procedural adverse events